Adaptive and Time-Sensitive Machine Learning Framework for Precision Therapy in Nontuberculous Mycobacterium Infections

Nontuberculous Mycobacterium (NTM) infections pose an increasing medical challenge due to their wide pathogen diversity, prolonged treatment lengths, and resistance to antibiotics. This research developed an innovative, adaptable artificial intelligence learning platform designed to customize NTM therapy method through the immediate collection of patient-specific ongoing data, including microbiological profiles, pharmacokinetic parameters, radiographic assessments, and responses to clinical treatment. This design employed recurrent neural networks to model temporal disease progression (with 79.1% sensitivity and 83.4% specificity for treatment failure prediction), Bayesian change-point analysis to identify critical shifts in patient status (with 85.6% sensitivity and 74.3% specificity for detecting clinical transitions such as emerging resistance or toxicity), and reinforcement learning algorithms to generate tailored therapeutic recommendations through outcome simulation. The study is an indication that there is an increase in the elimination of microbial infections resulting in a reduction of resistance emergence when this model is used, thereby surpassing conventional treatment strategies. These results indicate that using an adaptive machine learning framework for treatment could significantly improve clinical outcomes in NTM infection management. Prospective validation will be essential for the translation of these machine learning-powered precision therapy models from the research setting to the clinical environment to thoroughly evaluate their safety, clinical benefits, and the extent to which they can be used for treatment response.